Samalin Investment Counsel, LLC Novo Cure LTD Transaction History

Samalin Investment Counsel, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $16,980 - $26,970	-300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $6,676 - $9,381	-111 Reduced 27.01%	300 $24.9 Million
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $53,594 - $92,713	411 New	411 $91,000
Q1 2021 May 11, 2021	SELL	$124.11 - $190.17 $51,009 - $78,159	-411 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$58.05 - $111.31 $23,858 - $45,748	411 New	411 $45,000
Q1 2020 May 04, 2020	SELL	$57.05 - $95.75 $23,447 - $39,353	-411 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$68.3 - $93.8 $28,071 - $38,551	411 New	411 $34,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.